| Financial Year |
March 31 2023 |
| Monetary Funds |
1,613,001,929.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
61,798,885.93 |
| Accounts Receivable |
5,725,807,084.11 |
| Advances to Suppliers |
311,350,467.17 |
| Other Receivables |
49,894,658.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
451,476,066.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
214,753,987.73 |
| Total Current Assets |
9,461,554,464.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
358,991,119.16 |
| Investment Properties |
-- |
| Fixed Assetes |
553,831,415.57 |
| Under-construction Projects |
350,784,547.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
706,612,244.72 |
| R&D expenses |
388,797,471.09 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,623,658.18 |
| Deferred Income Tax Assets |
47,176,169.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,531,102,095.32 |
| Total Assets |
11,992,656,560.01 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
442,297,546.11 |
| Accounts Payable |
4,956,069,494.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,703,336.51 |
| Taxes Payable |
104,951,588.76 |
| Interest Payable |
-- |
| Dividend Payable |
46,346,070.81 |
| Other payables |
174,705,696.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,939,028.54 |
| Other Current Liabilities |
66,572,120.19 |
| Sub-Total of Current Liabilities |
6,165,272,535.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
369,819.60 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,616,679.22 |
| Total Liabilities |
6,185,889,214.56 |
| Paid-In Capital(Or Share Stock) |
1,202,669,044.00 |
| Capital Surplus |
1,498,773,308.63 |
| Surplus Reserve |
256,732,579.56 |
| LESS:Treasury Stock |
67,289,125.00 |
| Undistributed Profits |
2,915,297,561.85 |
| Minority Stockholder's Interest |
583,976.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,806,183,369.04 |
| Owner's Equity（Stockholder's Equity） |
5,806,767,345.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,992,656,560.01 |
